Trial Profile
A multicenter, double-blind, randomized trial of the relationship of intragastric acid control and healing status of moderate to severe erosive esophagitis after treatment with esomeprazole magnesium (Nexium) 10mg and 40mg once daily
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2010
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Therapeutic Use
- 05 Nov 2005 New trial record.